These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30909027)

  • 1. Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using
    Ishibashi K; Miura Y; Toyohara J; Ishiwata K; Ishii K
    Neuroimage Clin; 2019; 22():101783. PubMed ID: 30909027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain
    Ishibashi K; Miura Y; Wagatsuma K; Kameyama M; Ishii K
    J Neuroimaging; 2021 Sep; 31(5):864-868. PubMed ID: 34143915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A (11)C-ITMM PET study.
    Ishibashi K; Miura Y; Ishikawa K; Ishii K; Ishiwata K
    J Neurol Sci; 2015 Aug; 355(1-2):202-5. PubMed ID: 26055313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia.
    Ishibashi K; Miura Y; Ishikawa K; Zhang MR; Toyohara J; Ishiwata K; Ishii K
    J Neurol; 2016 Nov; 263(11):2179-2187. PubMed ID: 27502082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of imaging using
    Ishibashi K; Miura Y; Toyohara J; Ishii K; Ishiwata K
    J Neurol Sci; 2017 Apr; 375():97-102. PubMed ID: 28320199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography.
    Toyohara J; Sakata M; Fujinaga M; Yamasaki T; Oda K; Ishii K; Zhang MR; Moriguchi Jeckel CM; Ishiwata K
    Nucl Med Biol; 2013 Feb; 40(2):214-20. PubMed ID: 23265669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.
    Toyohara J; Sakata M; Oda K; Ishii K; Ito K; Hiura M; Fujinaga M; Yamasaki T; Zhang MR; Ishiwata K
    J Nucl Med; 2013 Aug; 54(8):1302-7. PubMed ID: 23804329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [11C]ITMM with Ultra-High Specific Activity in Small-Animal PET.
    Yamasaki T; Fujinaga M; Yui J; Wakizaka H; Ohya T; Nengaki N; Ogawa M; Ikoma Y; Hatori A; Xie L; Kawamura K; Zhang MR
    PLoS One; 2015; 10(6):e0130006. PubMed ID: 26076143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
    Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased 5-HT
    Mattsson P; Cselényi Z; Andrée B; Borg J; Nag S; Halldin C; Farde L
    Synapse; 2022 Jun; 76(7-8):e22235. PubMed ID: 35587913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression.
    Kim JH; Joo YH; Son YD; Kim JH; Kim YK; Kim HK; Lee SY; Ido T
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):278-290. PubMed ID: 30553696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring neuroprotective effects using positron emission tomography with [11C]ITMM, a radiotracer for metabotropic glutamate 1 receptor.
    Yui J; Xie L; Fujinaga M; Yamasaki T; Hatori A; Kumata K; Nengaki N; Zhang MR
    Stroke; 2013 Sep; 44(9):2567-72. PubMed ID: 23908068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Monitoring for Regional Changes of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Pilocarpine-Induced Epileptic Rat Brain by Small-Animal PET.
    Yamasaki T; Fujinaga M; Mori W; Zhang Y; Wakizaka H; Nengaki N; Xie L; Hatori A; Zhang MR
    Sci Rep; 2017 Nov; 7(1):14945. PubMed ID: 29097780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
    Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
    Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.